Figure 3
Time to discontinuation of TKI (a), progression-free survival (b) and overall survival (c) curves of patients with miliary (blue line) and non-miliary (green line) lung metastasis.
Figure 3 | Scientific Reports
Time to discontinuation of TKI (a), progression-free survival (b) and overall survival (c) curves of patients with miliary (blue line) and non-miliary (green line) lung metastasis.
